Global Scoliosis Treatment Market Research Report: Information by Disease (Infantile Idiopathic Scoliosis and Adolescent Idiopathic Scoliosis), Product (Cervical Thoracic Lumbar Sacral Orthosis (CTLSO), Thoracolumbosacral Orthosis (TLSO) and Lumbosacral Orthosis (LSO)), Distribution Channel (Hospitals & Clinics, Retail Pharmacies and Online Pharmacies) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
ID: MRFR/HC/6758-HCR | February 2021 | Region: Global | 95 pages
Market Scenario
The Global Scoliosis Treatment Market is expected to register a CAGR of ~ 3.9% during the forecast period of 2019 to 2025 with a market value of USD 2,580.2 million in 2018.
Scoliosis is an abnormal curve in the spinal cord. Depending on the severity of the curve and the risk of it deteriorating, scoliosis can be treated with bracing or surgery. There is no cure for scoliosis, but the pain can be alleviated. The global scoliosis treatment market is driven by factors such as the increasing prevalence of scoliosis and the high adoption rate of braces to reduce the severe pain. Additionally, the growing demand for spine surgeries coupled with the growing incidence of musculoskeletal disorders are anticipated to fuel the market growth. For instance, as per the National Scoliosis Foundation (NSF), around 2% to 3% of the general population, approximately 7 million people, encounter scoliosis in the US. On the other hand, the high cost of treatment or procedures is projected to hamper the growth of the market during the assessment period. Moreover, major companies in the market are involved in strategic product approvals, acquisitions, collaborations, and mergers to sustain their position in the market.
For instance, in August 2019, Zimmer Biomet Holdings Inc. announced it had received FDA approval of ‘Tether,’ the first spinal device intended for children and adolescents to correct idiopathic scoliosis that has not responded to conservative treatment
Segmentation
The global scoliosis treatment market has been segmented based on disease, product, distribution channel, and region. The market, based on disease, has been bifurcated into infantile idiopathic scoliosis and adolescent idiopathic scoliosis. The product segment has been further divided into cervical, thoracic, lumbar-sacral orthosis (CTLSO), thoracolumbosacral orthosis (TLSO), and lumbosacral orthosis (LSO). The distribution channel segment has been segregated into hospitals & clinics, retail pharmacies, and online pharmacies. The market has been classified, by region, like the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The scoliosis treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European scoliosis treatment market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The scoliosis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The scoliosis treatment market in the Middle East & Africa has been categorized as the Middle East and Africa.
Key Players
- Boston Orthotics & Prosthetics
- Chaneco
- Charleston Bending Brace
- Orthotech
- Trulife
- Össur
- DJO
- SPINEFORM LLC
- Wilmington Orthotics & Prosthetics, Inc.
- Lawall Prosthetics and Orthotics
- Horton's Orthotics & Prosthetics
- Aspen Medical Products
- UNYQ
- C H Martin Company
- Optec USA, Inc.
- Spinal Technology, Inc.
- Zimmer Biomet Holdings Inc.
- NuVasive
Regional Market Summary
Global scoliosis Treatment Market Share by Region, 2018 (%)
Source: World Health Organization (WHO)
The market in the Americas is expected to dominate the global scoliosis treatment market due to the increasing per capita healthcare expenditure and the high adoption of new technology in the region. High cases of scoliosis in the US and Canada is expected to drive the market growth.
Furthermore, increasing expenses in research by healthcare bodies is expected to fuel the growth of the market in this region. The market in Europe showed a considerable amount of growth. This can be attributed to the presence of a well-established healthcare system, the advancement of technology, and the involvement of critical companies. For instance, in January 2016, NuVasive Inc., acquired Ellipse Technologies the acquisition of Ellipse will aggressively insert NuVasive into early-onset and idiopathic scoliosis, an important and attractive part of the spinal deformity market for NuVasive where it has tremendous opportunities for accelerated growth in the scoliosis treatment market. Therefore, the market is expected to grow during the forecast period. The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing demand for spine surgeries and increasing government initiatives for healthcare reforms. The market in the Middle East & Africa is projected to account for the least share of the global market due to low disposable income in the region.
Global scoliosis Treatment Market, by Disease
- Infantile Idiopathic Scoliosis
- Adolescent Idiopathic Scoliosis
Global Scoliosis Treatment Market, by Product
- Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
- Thoracolumbosacral Orthosis (TLSO)
- Lumbosacral Orthosis (LSO)
Global Scoliosis Treatment Market, by Distribution channel
- Hospitals & Clinics
- Retail Pharmacies
- Online Pharmacies
Global Scoliosis Treatment Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Medical device companies
- Government research institutes
- Academic institutes and universities
- Venture capitalists
Frequently Asked Questions (FAQ) :
The scoliosis treatment market is projected to grow at a 3.9% CAGR between 2019-2025.
The Americas are predicted to have the largest share in the scoliosis treatment market.
Rising prevalence of scoliosis & musculoskeletal disorders and growing demand for spine injuries are boosting market growth.
Lack of awareness and high cost may restrict market growth.
Hospitals and clinics will dominate the scoliosis treatment market?
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Product Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Scoliosis Treatment Market, by Disease
6.1 Introduction
6.2 Infantile Idiopathic Scoliosis
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Adolescent Idiopathic Scoliosis
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Scoliosis Treatment Market, by Product
8.1 Introduction
8.2 Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Thoracolumbosacral Orthosis (TLSO)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Lumbosacral Orthosis (LSO)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9. Global Scoliosis Treatment Market, by Distribution channel
9.1 Introduction
9.2 Hospitals & Clinics
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.3 Retail Pharmacies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.4 Online Pharmacies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 10. Market Estimates & Forecast, by Country, 2020-2027
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
Chapter 12. Company Profiles
12.1 Boston Orthotics & Prosthetics
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.2 Chaneco
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Charleston Bending Brace
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Orthotech
12.4.1 Company Overview
12.4.2 Product Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Trulife
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Össur
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 DJO
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financial Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 SPINEFORM LLC
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Wilmington Orthotics & Prosthetics, Inc.
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Lawall Prosthetics and Orthotics
12.10.1 Overview
12.10.2 Product Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Horton's Orthotics & Prosthetics
12.11.1 Overview
12.11.2 Product Overview
12.11.3 Financials
12.11.4 Key Developments
12.11.5 SWOT Analysis
12.12 Aspen Medical Products
12.12.1 Overview
12.12.2 Product Overview
12.12.3 Financials
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.13 UNYQ
12.13.1 Overview
12.13.2 Product Overview
12.13.3 Financials
12.13.4 Key Developments
12.13.5 SWOT Analysis
12.14 C H Martin Company
12.14.1 Overview
12.14.2 Product Overview
12.14.3 Financials
12.14.4 Key Developments
12.14.5 SWOT Analysis
12.15 Optec USA, Inc.
12.15.1 Overview
12.15.2 Product Overview
12.15.3 Financials
12.15.4 Key Developments
12.15.5 SWOT Analysis
12.16 Spinal Technology, Inc.
12.16.1 Overview
12.16.2 Product Overview
12.16.3 Financials
12.16.4 Key Developments
12.16.5 SWOT Analysis
12.17 Zimmer Biomet Holdings Inc.
12.17.1 Overview
12.17.2 Product Overview
12.17.3 Financials
12.17.4 Key Developments
12.17.5 SWOT Analysis
12.18 NuVasive
12.18.1 Overview
12.18.2 Product Overview
12.18.3 Financials
12.18.4 Key Developments
12.18.5 SWOT Analysis
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Cell Surface Markers Industry
Chapter 14. Appendix
LIST OF TABLES
Table 1 Global Scoliosis Treatment Market Synopsis, 2020-2027
Table 2 Global Scoliosis Treatment Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Scoliosis Treatment Market, by Region, 2020-2027 (USD Million)
Table 4 Global Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)
Table 5 Global Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)
Table 6 Global Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)
Table 7 North America: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)
Table 8 North America: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)
Table 9 North America: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)
Table 10 Latin America: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)
Table 11 Latin America: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)
Table 12 Latin America: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)
Table 13 Europe: Scoliosis Treatment Market, by Disease tye, 2020-2027 (USD Million)
Table 14 Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)
Table 15 Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)
Table 16 Western Europe: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)
Table 17 Western Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)
Table 18 Western Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)
Table 19 Eastern Europe: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)
Table 20 Eastern Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)
Table 21 Eastern Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)
Table 22 Asia-Pacific: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)
Table 23 Asia-Pacific: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)
Table 24 Asia-Pacific: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)
Table 25 Middle East & Africa: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)
Table 26 Middle East & Africa: Scoliosis Treatment Market, by Product, 2020-2027
(USD Million)
Table 27 Middle East & Africa: Scoliosis Treatment Market, by Distribution channel, 2020-2027
(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Market Structure for Global Scoliosis Treatment Market
Figure 3 Market Dynamics for Global Scoliosis Treatment Market
Figure 4 Global Scoliosis Treatment, by Disease, 2020
Figure 5 Global Scoliosis Treatment Market Share, by Product, 2020
Figure 6 Global Scoliosis Treatment Market Share, by Distribution channel, 2020
Figure 7 Global Scoliosis Treatment Market Share, by Region, 2020
Figure 8 North America: Scoliosis Treatment Market Share, by Country, 2020
Figure 9 Europe: Scoliosis Treatment Market Share, by Country, 2020
Figure 10 Asia-Pacific: Scoliosis Treatment Market Share, by Country, 2020
Figure 11 Middle East & Africa: Scoliosis Treatment Market Share, by Country, 2020
Figure 12 Global Scoliosis Treatment Market: Company Share Analysis, 2020 (%)
Figure 13 Boston Orthotics & Prosthetics, Inc.: Key Financials
Figure 14 Boston Orthotics & Prosthetics, Inc.: Segmental Revenue
Figure 15 Boston Orthotics & Prosthetics, Inc.: Geographical Revenue
Figure 16 Chaneco Medical Solutions: Key Financials
Figure 17 Chaneco Medical Solutions: Segmental Revenue
Figure 18 Chaneco Medical Solutions: Geographical Revenue
Figure 19 Charleston Bending Brace: Key Financials
Figure 20 Charleston Bending Brace: Segmental Revenue
Figure 21 Charleston Bending Brace: Geographical Revenue
Figure 22 Orthotech: Key Financials
Figure 23 Orthotech: Segmental Revenue
Figure 24 Orthotech: Geographical Revenue
Figure 25 Trulife: Key Financials
Figure 26 Trulife: Segmental Revenue
Figure 27 Trulife: Geographical Revenue
Figure 28 Össur: Key Financials
Figure 29 Össur: Segmental Revenue
Figure 30 Össur: Geographical Revenue
Figure 31 DJO: Key Financials
Figure 32 DJO: Segmental Revenue
Figure 33 DJO: Geographical Revenue
Figure 34 SPINEFORM LLC: Financials
Figure 35 SPINEFORM LLC: Segmental Revenue
Figure 36 SPINEFORM LLC: Geographical Revenue
Figure 37 Wilmington Orthotics & Prosthetics, Inc.: Key Financials
Figure 38 Wilmington Orthotics & Prosthetics, Inc.: Segmental Revenue
Figure 39 Wilmington Orthotics & Prosthetics, Inc.: Geographical Revenue
Figure 40 Lawall Prosthetics and Orthotics: Key Financials
Figure 41 Lawall Prosthetics and Orthotics: Segmental Revenue
Figure 42 Lawall Prosthetics and Orthotics: Geographical Revenue
Figure 43 Horton's Orthotics & Prosthetics: Key Financials
Figure 44 Horton's Orthotics & Prosthetics: Segmental Revenue
Figure 45 Horton's Orthotics & Prosthetics: Geographical Revenue
Figure 46 Aspen Medical Products: Key Financials
Figure 47 Aspen Medical Products: Segmental Revenue
Figure 48 Aspen Medical Products: Geographical Revenue
Figure 49 UNYQ: Key Financials
Figure 50 UNYQ: Segmental Revenue
Figure 51 UNYQ: Geographical Revenue
Figure 52 C H Martin Company: Key Financials
Figure 53 C H Martin Company: Segmental Revenue
Figure 54 C H Martin Company: Geographical Revenue
Figure 55 Optec USA, Inc.: Key Financials
Figure 56 Optec USA, Inc.: Segmental Revenue
Figure 57 Optec USA, Inc.: Geographical Revenue
Figure 58 Spinal Technology, Inc.: Key Financials
Figure 59 Spinal Technology, Inc.: Segmental Revenue
Figure 60 Spinal Technology, Inc.: Geographical Revenue
Figure 61 Zimmer Biomet Holdings Inc.: Key Financials
Figure 62 Zimmer Biomet Holdings Inc.: Segmental Revenue
Figure 63 Zimmer Biomet Holdings Inc.: Geographical Revenue
Figure 64 NuVasive: Key Financials
Figure 65 NuVasive: Segmental Revenue
Figure 66 NuVasive: Geographical Revenue
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.